查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448487

心血管器材市場：趨勢、機會與競爭分析

Cardiovascular Device Market: Trends, Opportunities and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球心血管設備市場預計將達到1,158億美元，預計2024年至2030年年複合成長率為4.8%。市場成長的主要驅動力是微創手術需求的增加、醫療保健支出的增加以及老年人口的增加。

直接影響心血管設備產業動態的新興趨勢包括對可攜式心臟監測設備的需求增加、經導管主動脈瓣置換術(TAVR) 的採用增加以及生物可吸收支架的使用增加。

本研究提供了到 2028 年的全球心血管設備市場規模和預測，按類型、設備和地區分類如下：

該市場中的一些心血管設備公司包括美敦力公共有限公司、波士頓科學公司、雅培實驗室、愛德華茲生命科學公司和強生公司。

基於綜合研究，Lucintel 預計結構心臟設備、電生理、心臟輔助設備、診斷和監測設備領域在預測期內將呈現高於平均值的成長。

CRM 領域預計仍將是全球心血管設備市場中最大的市場。心臟去顫器的使用量不斷增加主要是因為成本效益和安全性，預計這將導致 CRM 市場的顯著成長。

預計北美在預測期內仍將是最大的市場，這主要是由於該地區存在大量合格患者群，且先進治療的採用率很高。

本報告的特點

  • 市場規模/估計： 市場規模/估計：以出貨收益計算的全球心血管設備市場規模估計（百萬美元）。
  • 趨勢和預測分析：按細分市場和地區分類的市場趨勢（2018-2023）和預測（2024-2030）。
  • 細分市場分析：按類型、設備和各種用途的金額和出貨收益預測全球心血管設備市場規模。
  • 區域分析：按北美、歐洲、亞洲等主要地區分類的全球心血管設備市場細分。
  • 成長機會：分析心血管設備市場不同應用和地區的成長機會。
  • 策略分析：包括併購、新產品開發、全球心血管設備市場競爭格局等。
  • 基於波特五力模型的產業競爭實力分析。

本報告解決了以下關鍵問題：

  • Q.1. 按類型、設備和地區分類，全球心血管設備市場最有前景和高成長的機會是什麼？
  • Q.2.哪些產品領域預計將以更快的速度成長？
  • Q.3.您認為哪些地區未來會出現更快的成長？
  • Q.4. 影響市場動態的關鍵因素是什麼？心血管設備市場的市場促進因素、挑戰和商業風險是什麼？
  • Q.5. 這個心血管設備市場的商業風險和競爭威脅是什麼？
  • Q.6.心血管設備市場的新趨勢是什麼？
  • Q.7. 心血管設備市場的客戶需求有何改變？
  • Q.8. 心血管設備市場有哪些新開拓？
  • Q.9. 心血管設備市場的主要企業有哪些？主要企業正在採取哪些策略舉措來發展業務？
  • Q.10. 這個心血管設備市場市場佔有率哪些競爭產品？
  • Q.11.過去五年心血管設備市場發生了哪些併購？

目錄

第1章執行摘要

第2章 市場背景及分類

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢和預測
  • 全球心血管設備市場趨勢及預測
  • 按類型分類的全球心血管設備市場
    • 心律管理 (CRM)
    • 心臟介入裝置
    • 週邊血管裝置
    • 心臟輔助裝置
    • 結構性心臟裝置
    • 心血管外科
    • 電生理學
    • 診斷和監測設備
  • 按設備分類的全球心血管設備市場
    • 心律調節器
    • 心臟去顫器
    • 支架
    • 心導管
    • 導管導引線
    • 心臟瓣膜
    • 心電圖（ECG）
    • 心臟事件記錄器
    • 其他

第4章 區域市場趨勢及預測分析

  • 全球心血管設備市場區域分佈
  • 北美心血管設備市場
  • 歐洲心血管設備市場
  • 亞太心血管設備市場
  • 其他地區心血管設備市場

第5章 競爭分析

  • 產品系列分析
  • 市場佔有率分析
  • 營運整合
  • 地理範圍
  • 波特五力分析

第6章成本結構分析

  • 銷貨成本
  • 銷售、一般及管理費用
  • EBITDA獲利率

第7章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球心血管設備市場成長機會
    • 全球心血管設備市場成長機會（按設備）
    • 按地區分類的全球心血管設備市場成長機會
  • 全球心血管設備市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球心血管器材市場的產能
    • 全球心血管設備市場的併購和合資企業
    • 技術開發

第8章主要企業概況

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronic Public Limited Company
  • CR Bard, Inc.
  • Johnson & Johnson
  • St. Jude Medical Inc.
  • Cook Medical Inc.
  • Terumo Corporation
  • Cardinal Health Inc.
簡介目錄

The global cardiovascular device market is expected to reach an estimated $115.8 billion by 2030 and it is forecast to grow at a CAGR of 4.8% from 2024 to 2030. The major drivers for market growth are growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.

Emerging trends which have a direct impact on the dynamics of the cardiovascular device industry include increasing demand of portable heart monitoring devices, rising adoption of transcatheter aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable stents.

A total of 112 figures / charts and 84 tables are provided in this 197-page report to help in your business decisions. Sample figures with some insights are shown below.

The study includes the cardiovascular device market size and a forecast for the global cardiovascular device market through 2028, segmented by type, device, and region, as follows:

Cardiovascular Device Market by Type [Value ($ Million) from 2018 to 2030]:

  • Cardiac Rhythm Management
  • Interventional Cardiac Devices
  • Peripheral Vascular Devices
  • Cardiac Assist Devices
  • Structural Heart Devices
  • Cardiovascular Surgery
  • Electrophysiology
  • Diagnostic & Monitoring Devices

Cardiovascular Device Market by Device [Value ($ Million) from 2018 to 2030]:

  • Pacemaker
  • Defibrillator
  • Stent
  • Cardiac Catheter
  • Guidewire
  • Heart Valve
  • ECG
  • Event Monitor
  • Others

Cardiovascular Device Market by Region [Value ($ Million) from 2018 to 2030]:

  • North America
  • United States
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • India
  • ROW
  • Brazil

Cardiovascular device companies profiled in this market include Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major suppliers of cardiovascular devices.

On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.

Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.

North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.

Some of the features of this report:

  • Market size estimates: Global cardiovascular device market size estimation in terms of value ($M) shipment.
  • Trend and forecast analysis:Market trend (2018-2023) and forecast (2024-2030) by segments and region.
  • Segmentation analysis: Global cardiovascular device market size by various applications such as type, and device in terms of value and volume shipment.
  • Regional analysis: Global cardiovascular device market breakdown by key regions such as North America, Europe, and Asia & Rest of World.
  • Growth opportunities: Analysis on growth opportunities in different applications and regions of cardiovascular device market.
  • Strategic analysis:This includes M&A, new product development, and competitive landscape of global cardiovascular device market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report addresses the following key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for global cardiovascular device market by type, which includes cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices, by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which products segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this cardiovascular device market?
  • Q.5. What are the business risks and competitive threats in this cardiovascular device market?
  • Q.6. What are the emerging trends in this cardiovascular device market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the cardiovascular device market?
  • Q.8. What are the new developments in the cardiovascular device market and which companies are leading these developments?
  • Q.9. Who are the major players in this cardiovascular device market? What strategic initiatives are being taken by key companies for business growth?
  • Q.10. What are some of the competing products in this cardiovascular device market and how big of a threat do they pose for loss of market share by product substitution?
  • Q.11. What M&A activity has occurred in thecardiovascular device market during last 5 years?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Cardiovascular Device Market Trends and Forecast
  • 3.3: Global Cardiovascular Device Market by Type
    • 3.3.1: Cardiac Rhythm Management (CRM)
    • 3.3.2: Interventional Cardiac Devices
    • 3.3.3: Peripheral Vascular Devices
    • 3.3.4: Cardiac Assist Devices
    • 3.3.5: Structural Heart Devices
    • 3.3.6: Cardiovascular Surgery
    • 3.3.7: Electrophysiology
    • 3.3.8: Diagnostic & Monitoring Devices
  • 3.4: Global Cardiovascular Device Market by Device
    • 3.4.1: Pacemaker
    • 3.4.2: Defibrillator
    • 3.4.3: Stent
    • 3.4.4: Cardiac Catheter
    • 3.4.5: Guidewire
    • 3.4.6: Heart Valve
    • 3.4.7: Electrocardiogram (ECG)
    • 3.4.8: Event Monitor
    • 3.4.9: Others

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Cardiovascular Device Market by Region
  • 4.2: North American Cardiovascular Device Market
    • 4.2.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.2.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.2.3: The United States Cardiovascular Device Market
  • 4.3: European Cardiovascular Device Market
    • 4.3.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.3.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.3.3: Cardiovascular Device Market of Germany
    • 4.3.4: The French Cardiovascular Device Market
    • 4.3.5: Cardiovascular Device Market of the United Kingdom
    • 4.3.6: The Italian Cardiovascular Device Market
    • 4.3.7: The Spanish Cardiovascular Device Market
  • 4.4: APAC Cardiovascular Device Market
    • 4.4.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.4.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.4.3: Japanese Cardiovascular Device Market
    • 4.4.4: The Chinese Cardiovascular Device Market
    • 4.4.5: Indian Cardiovascular Device Market
  • 4.5: ROW Cardiovascular Device Market
    • 4.5.1: Market by Type: Cardiac Rhythm Management, Interventional Cardiac Device, Peripheral Vascular Device, Cardiac Assist Device, Structural Heart Device, Cardiovascular Surgery, Electrophysiology, and Diagnostic & Monitoring Device
    • 4.5.2: Market by Device: Pacemaker, Defibrillator, Stent, Cardiac Catheter, Guidewire, Heart Valve, ECG, Event Monitor, and Others
    • 4.5.3: Brazilian Cardiovascular Device Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Operational Integration
  • 5.4: Geographical Reach
  • 5.5: Porter's Five Forces Analysis

6. Cost Structure Analysis

  • 6.1: Cost of Goods Sold
  • 6.2: SG&A
  • 6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis

  • 7.1: Growth Opportunity Analysis
    • 7.1.1: Growth Opportunities for the Global Cardiovascular Device Market by Type
    • 7.1.2: Growth Opportunities for the Global Cardiovascular Device Market by Device
    • 7.1.3: Growth Opportunities for the Global Cardiovascular Device Market by Region
  • 7.2: Emerging Trends in the Global Cardiovascular Device Market
  • 7.3: Strategic Analysis
    • 7.3.1: New Product Development
    • 7.3.2: Capacity Expansion of the Global Cardiovascular Device Market
    • 7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiovascular Device Market
    • 7.3.4: Technology Development

8. Company Profiles of Leading Players

  • 8.1: Abbott Laboratories
  • 8.2: Boston Scientific Corporation
  • 8.3: Edwards Lifesciences Corporation
  • 8.4: Medtronic Public Limited Company
  • 8.5: C. R. Bard, Inc.
  • 8.6: Johnson & Johnson
  • 8.7: St. Jude Medical Inc.
  • 8.8: Cook Medical Inc.
  • 8.9: Terumo Corporation
  • 8.10: Cardinal Health Inc.